www.marijuanamoment.net Open in urlscan Pro
2606:4700:3032::6815:17e7  Public Scan

URL: https://www.marijuanamoment.net/gop-senator-is-wrong-about-international-treaties-preventing-marijuana-rescheduling-cannabis-com...
Submission: On April 23 via manual from US — Scanned from US

Form analysis 3 forms found in the DOM

GET https://www.marijuanamoment.net/

<form method="get" id="searchform" action="https://www.marijuanamoment.net/">
  <input type="text" name="s" id="s" value="Search" onfocus="if (this.value == &quot;Search&quot;) { this.value = &quot;&quot;; }" onblur="if (this.value == &quot;&quot;) { this.value = &quot;Search&quot;; }">
  <input type="hidden" id="searchsubmit" value="Search">
</form>

POST

<form id="mc4wp-form-2" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">Get our daily newsletter. <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1713836110"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-2">
  <div class="mc4wp-response"></div>
</form>

POST

<form id="mc4wp-form-3" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">Get our daily newsletter. <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1713836111"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-3">
  <div class="mc4wp-response"></div>
</form>

Text Content

 * Politics
 * Science & Health
 * Culture
 * Business
 * Video
 * Newsletter
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2024 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter

Connect with us
 * 
 * 
 * 


MARIJUANA MOMENT

GOP SENATOR IS WRONG ABOUT INTERNATIONAL TREATIES PREVENTING MARIJUANA
RESCHEDULING, CANNABIS COMPANIES AND ADVOCACY ORGANIZATIONS SAY


 * Politics
   
    * Hawaii Senate Rejects Marijuana Decrim Expansion Bill, While Expungements
      Legislation Heads To Governor
   
    * Three In Five Americans Say Marijuana Is Safer Than Alcohol Or Tobacco,
      Survey Finds
   
    * South Carolina Lawmakers Will Take Up Senate-Passed Medical Marijuana Bill
      This Week, Earning Praise From GOP Congresswoman
   
    * Montana Lawmakers Fail To Override Governor’s Veto Of Marijuana Revenue
      Distribution Bill
   
    * Vermont Senate Panels Advance Safe Drug Consumption Site Bill After
      Narrowing Scope To A Single Burlington Facility

 * Science & Health
   
    * CBD Is A ‘Powerful And Promising’ Treatment For Crack Use Disorder—With
      Fewer Side Effects Than Conventional Therapies, Study Finds
   
    * Marijuana Legalization Reduces Likelihood Of Teen Use, Study Published By
      American Medical Association Finds
   
    * Medical Marijuana Patient Enrollment Grew 610% Since 2016, Showing
      ‘Increasing Cultural Acceptance Of Cannabis,’ Federal Study Finds
   
    * Use Of Psilocybin For Mental Health Treatment ‘Not Associated’ With Risk
      Of Paranoia, American Medical Association Study Finds
   
    * More Than 90% Of Smokable Hemp Samples Analyzed By Researchers Contained
      Illegal Amounts Of THC, New Federal Study Finds

 * Culture
   
    * Brands And Advocacy Groups—From ACLU To KFC—Launch 4/20 Promotions To Mark
      The Marijuana Holiday
   
    * Former Minnesota Gov. Jesse Ventura Promotes New Cannabis Brand Ahead Of
      4/20 That He’d ‘Offer To You’ On Governor’s Mansion Visit
   
    * Colorado Amendment Addresses Concerns On Banning Social Media Marijuana
      Posts, But Questions On Psychedelics And Other Drugs Remain
   
    * Former Minnesota Governor Jesse Ventura Launches His Own Cannabis Brand,
      Fulfilling A ‘Lifelong Dream’
   
    * Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To
      Smoke Weed’ For $70,420 Salary

 * Business
   
    * Legal Marijuana Purchases In Michigan Spiked In March, Reaching A New
      Record High
   
    * The Legal Marijuana Industry Now Supports More Than 440,000 Full-Time
      Jobs, Up 5% From Last Year, Report Finds
   
    * Missouri Warns Marijuana License Applicants Of ‘Predatory Practices’
      Around Social Equity Status
   
    * Missouri Marijuana Worker Union Dispute Could Have Major Implications For
      National Labor Law
   
    * New Mexico Retailers Set A New Marijuana Sales Record In March

 * Video
   
    * Hawaii Senate Rejects Marijuana Decrim Expansion Bill, While Expungements
      Legislation Heads To Governor
   
    * Vermont Senate Panels Advance Safe Drug Consumption Site Bill After
      Narrowing Scope To A Single Burlington Facility
   
    * Joe Biden And Kamala Harris Tweet About Marijuana At Exactly 4:20 On 4/20
   
    * Ahead Of 4/20 White House Says Biden Has Been ‘Very Clear’ In Supporting
      Marijuana Decriminalization, But Admin Is Awaiting DOJ Rescheduling Action
   
    * New Hampshire Lawmakers Weigh Medical Marijuana Expansion Bills Amid
      Recreational Legalization Debate

 * Newsletter
   
    * Biden celebrates 4/20 with cannabis reform push (Newsletter: April 22,
      2024)
   
    * Senate cannabis expungements bill (Newsletter: April 19, 2024)
   
    * Schumer & lawmakers talk cannabis as 4/20 approaches (Newsletter: April
      18, 2024)
   
    * Congressional cannabis & psychedelics votes (Newsletter: April 17, 2024)
   
    * White House cannabis rescheduling update (Newsletter: April 16, 2024)
   
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2024 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter




POLITICS


GOP SENATOR IS WRONG ABOUT INTERNATIONAL TREATIES PREVENTING MARIJUANA
RESCHEDULING, CANNABIS COMPANIES AND ADVOCACY ORGANIZATIONS SAY

Published

12 hours ago

on

April 22, 2024

By

Ben Adlin

Dozens of marijuana companies and advocacy groups are pushing back against Sen.
Mitt Romney’s (R-UT) recent claims that the U.S. would be in violation of
international drug treaty agreements if it reschedules cannabis to Schedule III
of the Controlled Substances Act (CSA).

In a letter sent to Romney this month, more than 50 organizations said the
senator made “inaccurate claims that neither reflect the current state of
medical and scientific knowledge about marijuana nor an accurate application of
relevant treaties to proposed reforms.”

Signatories—including major marijuana businesses, industry groups, law firms,
ancillary businesses and and cannabis advocacy organizations—said in the April 9
letter that they wanted to “correct the record.”

CBD Can Help Treat Pain, Cancer, Schizophrenia, COVID And Other Conditions

CBD Can Help Treat Pain, Cancer, Schizophrenia, COVID And Other Conditions
A new scientific review highlights CBD's potential to treat various conditions
such as epilepsy, pain, cancer, schizophrenia, diabetes, and COVID-19.  The
review aims to summarize cannabis's impact on human health, noting its
“neuroprotective, anti-inflammatory, and pain-relieving properties”. The study
delves into CBD's pharmacological properties, mechanisms of action, and its
potential medical applications.  It discusses CBD's role in treating epilepsy,
pain relief, managing schizophrenia symptoms, and its potential as a COVID-19
inhibitor.  The review also touches upon CBD's promising anticancer properties
and its effects on diabetes-related processes.  “Cannabis exhibits
neuroprotective, anti-inflammatory, anti-thrombotic, anti-bacterial, analgesic,
and antiepileptic properties.” Additionally, it acknowledges the industrial
applications of CBD and hemp in pharmaceuticals, skincare, fuel, paper,
clothing, rope, and massage oil production.
More Videos


0 seconds of 1 minute, 9 secondsVolume 0%

Press shift question mark to access a list of keyboard shortcuts
Keyboard ShortcutsEnabledDisabled
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9

Next Up
Cannabis May Be “Viable Alternative” Treatment For Dogs With Common Skin Disease
01:23
facebook twitter Email pinterest
Linkhttps://cdn.jwplayer.com/previews/KBYYUj9B
Copied
Live
00:00
01:48
01:09








 

Late last month, Romney and Sens. James Risch (R-ID) and Pete Ricketts (R-NE)
sent a letter to Drug Enforcement Administration (DEA) Administrator Anne
Milgram arguing that rescheduling marijuana—as recommended by the Department of
Health and Human Services (HHS)—would put the U.S. out of compliance with
international treaty obligations and make it harder to ensure that other
countries continue to enforce drug laws, “including for deadly narcotics like
fentanyl.”

The new industry and advocacy group response contends that Romney’s
understanding of the law is out of date.



“Your letter cites a 1977 decision from the U.S. Court of Appeals for the D.C.
Circuit describing obligations under the Single Convention that would not be met
if marijuana were reclassified under schedule III,” it says. “However, in the
many years since the court weighed in, the U.N. Commission on Narcotic Drugs
voted to reclassify cannabis in recognition of its medical uses. Moving
marijuana to schedule III, as recommended by HHS, simply acknowledges this
accepted reality.”

“The U.S. is not required under any applicable Treaty to keep marijuana in
schedule I or II under the CSA. So long as certain requirements are met, the
drug Treaties provide the U.S. with the flexibility to classify relevant
substances based on scientific and medical evidence and in accordance with
domestic laws such as the CSA. The U.S. Department of State addressed this in
the fall of 2023 during an intersessional meeting of the UN’s Commission on
Narcotic Drugs, stating that the Single Convention is primarily focused on drug
trafficking and has an international, rather than domestic, focus.”



Ever since news leaked in August that the Department of Health and Human
Services (HHS) had sent a recommendation to DEA that marijuana be rescheduled as
a Schedule III drug, some have warned that the move could still hit legal snags.
One of the open questions is whether U.S. interpretations of international drug
law would block the proposal.

Officials and advocates have interpreted the country’s duties under those
treaties in competing ways.



Among those who’ve raised concerns is Rep. Andy Harris (R-MD), who raised the
issue in a letter to DEA Administrator Milgram in January, claiming that any
reclassification that puts marijuana outside of Schedule I or Schedule II “would
constitute a violation of the Single Convention,” referring to the 1961 United
Nations (UN) Single Convention on Narcotic Drugs.

In 2016, DEA itself said in a denial of a cannabis rescheduling petition that
“in view of United States obligations under international drug control treaties,
marijuana cannot be placed in a schedule less restrictive than schedule II.”



But as a coalition of 12 senators pointed out in a separate letter to Milgram a
week before Harris’s was sent, the UN has since revised global cannabis
scheduling policies and allowed other member states, such as Canada, to legalize
and regulate marijuana without penalty. Those lawmakers urged DEA to legalize
marijuana completely.

Earlier this month, meanwhile, Canadian Prime Minister Justin Trudeau said his
government’s concern about possible United Nations (UN) penalties for legalizing
marijuana never materialized, disclosing that no officials have so much as
discussed the issue with Canada since the reform was enacted in 2018.

The prime minister was a chief proponent of legalization, and the government has
defended its decision to advance the reform—including at a meeting of the UN
Commission on Narcotic Drugs in 2020.



In February, a group of lawyers specializing in cannabis issued argued in a
legal opinion that international drug treaties ought not stand in the way of
moving marijuana to Schedule III. In fact, it said, a move to Schedule III would
better uphold the country’s broader obligations under international law to
regulate cannabis in a way that protects public health and safety.

The new letter to Romney echoes many of that opinion’s arguments.

“The current placement of marijuana under schedule I prevents the U.S. from
ensuring the substance’s availability for medical and scientific research as
required by the Single Convention,” it says. “Reclassification under schedule
III would, therefore, bring the U.S. closer to compliance with Treaty
requirements.”



Meanwhile, HHS has reportedly requested a legal opinion on the implications of
possible marijuana rescheduling from the Justice Department’s Office of Legal
Counsel (OLC), and some suspect it concerns the potential international treaty
consequences. Rep. Earl Blumenauer (D-OR) has requested clarification on the
request from HHS.

A Democratic congresswoman has separately implored DEA to “reject any argument”
that rescheduling marijuana under federal law would constitute a violation of
international treaty obligations. She also asked the agency to reveal a list of
any “outside partners” it has met with to discuss the global implications of a
potential cannabis reclassification.

The UN’s International Narcotics Control Board (INCB) did recently reiterate
that it considers legalizing marijuana for non-medical or non-scientific
purposes a violation of international treaties.



Here’s a full list of the groups that signed the recent letter to Romney, as
well as a copy of the letter itself:

 * Acreage Holdings
 * Ascend Wellness Holdings
 * Asian Americans for Cannabis Education
 * American Trade Association of Cannabis and Hemp AYR Wellness
 * Bada Bloom
 * Balanced Veterans Network
 * Cannabist Company
 * ConBud
 * Cresco Labs
 * Dutchie
 * Good Day Farm
 * Green Thumb Industries
 * Hemp for Victory
 * Hero Grown
 * Holistic Solutions
 * Holistic Industries
 * Housing Works
 * IAVA
 * Jushi Holdings
 * Justus Foundation
 * Kush Culture Industries
 * Law Enforcement Action Partnership
 * Lume Cannabis Co.
 * Major Bloom
 * Majority Minority Group Marcu Enterprises Marijuana Policy Project MoodiDay
 * National Cannabis Roundtable
 * National Hispanic Cannabis Council (NHCC) Native Roots Dispensary
 * New York CAURD Coalition
 * New York for Social and Economic Equity Perkins Coie LLP
 * PharmaCann Inc.
 * Phylos Bio
 * Physicians Research Center, LLC
 * Porter Wright
 * PPP Dispensary
 * Quality Roots
 * Queen City Remedies
 * Realm of Caring
 * Santa Cruz Veterans Alliance
 * Scotts Miracle-Gro
 * Simply Pure Trenton
 * Tetragram Inc.
 * The Bronx Community Foundation
 * The Travel Agency: A Cannabis Store
 * The Weldon Project
 * Trulieve
 * Tuatara Capital
 * United States Cannabis Council
 * Valley Wellness
 * Verano Holdings
 * Vicente LLP
 * Wana Brands
 * Wyld
 * Veterans Cannabis Project







> Marijuana Rescheduling Could ‘Ease Researcher Access’ For Studies, Federal
> Agency Says In Overdue Report To Congress



 

Marijuana Moment is made possible with support from readers. If you rely on our
cannabis advocacy journalism to stay informed, please consider a monthly Patreon
pledge.

Related Topics:featured

Up Next

Congressional Progressive Caucus Says Democrats Can Legalize Marijuana If They
Win House And Senate Majorities In November Election

Don't Miss

After Long Delay, Marijuana Social Equity Fund In Massachusetts Awards $2.3
Million In Grants To Cannabis Businesses

Ben Adlin


Ben Adlin, a senior editor at Marijuana Moment, has been covering cannabis and
other drug policy issues professionally since 2011. He was previously a senior
news editor at Leafly, an associate editor at the Los Angeles Daily Journal and
a Coro Fellow in Public Affairs. He lives in Washington State.



YOU MAY LIKE

Hawaii Senate Rejects Marijuana Decrim Expansion Bill, While Expungements
Legislation Heads To Governor

Three In Five Americans Say Marijuana Is Safer Than Alcohol Or Tobacco, Survey
Finds

South Carolina Lawmakers Will Take Up Senate-Passed Medical Marijuana Bill This
Week, Earning Praise From GOP Congresswoman

Montana Lawmakers Fail To Override Governor’s Veto Of Marijuana Revenue
Distribution Bill

Vermont Senate Panels Advance Safe Drug Consumption Site Bill After Narrowing
Scope To A Single Burlington Facility

Maine Governor Signs Bill Allowing Marijuana Convictions To Be Sealed Upon
Application


Advertisement

MARIJUANA NEWS IN YOUR INBOX

Get our daily newsletter.

Email address:



Leave this field empty if you're human:



SUPPORT MARIJUANA MOMENT








 * 
 * 
 * 

 * About Marijuana Moment
 * Subscribe
 * Sponsorship and Advertising
 * Privacy Policy

All the cannabis news you need, all in one place. Copyright © 2017-2024
Marijuana Moment LLC ® and Tom Angell

Information from your device can be used to personalize your ad experience.

Do not sell or share my personal information.
A Raptive Partner Site




MARIJUANA NEWS IN YOUR INBOX

 

Get our daily newsletter.

Email address:



Leave this field empty if you're human:





✕
Do not sell or share my personal information.
You have chosen to opt-out of the sale or sharing of your information from this
site and any of its affiliates. To opt back in please click the "Customize my ad
experience" link.

This site collects information through the use of cookies and other tracking
tools. Cookies and these tools do not contain any information that personally
identifies a user, but personal information that would be stored about you may
be linked to the information stored in and obtained from them. This information
would be used and shared for Analytics, Ad Serving, Interest Based Advertising,
among other purposes.

For more information please visit this site's Privacy Policy.
CANCEL
CONTINUE